Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00309348 · ClinicalTrials.gov registry record · NA
Ultrasound Instrument to Prevent Dialysis Graft Failure
A NA study, sponsored by DVX.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT00309348 is a NA study that has completed, run by DVX. The registered enrollment target is 111 participants.
The verdict
NCT00309348, a NA study, has completed, sponsored by DVX.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
This research study aims to show that a newly developed investigational Doppler instrument can reliably measure blood flow in dialysis access grafts, to see if a decrease in the flow may be a sign of impending graft failure and also to see if there is evidence that by monitoring the flow in these grafts their lives may be extended. The new investigational device is to be known as FloMon; this is an ultrasonic device that provides blood flow measurements from a small probe placed in a noninvasive manner above the graft or blood vessel. The instrument is being developed so that it may help give insight to on-coming graft failure which may be prevented. The FloMon is an extension of a previously Food and Drug Administration (FDA) cleared instrument, Echoflow-A, which had been used in a similar study as this one. The Echoflow-A is similar to this device in all respects with the exception of design and calculation of measurement. The FloMon compared to the Echoflow-A is better ergonomically designed and reads flow readings in about 2 minutes versus twice the time necessary to take similar measurements using the Echoflow-A.
Interventions
- OTHER Weekly measurement of graft flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2006-02-27 |
| Est. Completion | 2008-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00309348
The ClinicalTrials.gov registry entry for NCT00309348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DVX, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Weekly measurement of graft flow is the first listed.
NCT00309348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00309348 about?
NCT00309348 is a clinical study titled "Ultrasound Instrument to Prevent Dialysis Graft Failure". This research study aims to show that a newly developed investigational Doppler instrument can reliably measure blood flow in dialysis access grafts, to see if a decrease in the flow may be a sign of impending graft failure and also to see if there is evidence that by monitoring the flow in these gr...
What is the current status of trial NCT00309348?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2006-02-27. Estimated completion is 2008-04-30.
What interventions are being tested in trial NCT00309348?
The interventions under investigation include: Weekly measurement of graft flow (OTHER).
Who is sponsoring clinical trial NCT00309348?
This trial is sponsored by DVX, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.